These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38556586)
1. Fat mass and obesity-associated protein (FTO) mediated m Wu X; Fang Y; Gu Y; Shen H; Xu Y; Xu T; Shi R; Xu D; Zhang J; Leng K; Shu Y; Ma P Mol Biomed; 2024 Apr; 5(1):11. PubMed ID: 38556586 [TBL] [Abstract][Full Text] [Related]
2. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer. Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129 [TBL] [Abstract][Full Text] [Related]
3. RNA demethylase FTO participates in malignant progression of gastric cancer by regulating SP1-AURKB-ATM pathway. Zeng X; Lu Y; Zeng T; Liu W; Huang W; Yu T; Tang X; Huang P; Li B; Wei H Commun Biol; 2024 Jul; 7(1):800. PubMed ID: 38956367 [TBL] [Abstract][Full Text] [Related]
4. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer. Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548 [TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314 [TBL] [Abstract][Full Text] [Related]
6. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner. Yin Z; Guo X; Liang X; Wang Z Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333 [TBL] [Abstract][Full Text] [Related]
7. Novel evidence for m Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398 [TBL] [Abstract][Full Text] [Related]
8. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway. Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267 [TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer. Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441 [TBL] [Abstract][Full Text] [Related]
10. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515 [TBL] [Abstract][Full Text] [Related]
11. FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12. Chen Z; Zhong X; Xia M; Liu C; Tang W; Liu G; Yi Y; Guo Y; Jiang Q; Zu X; Zhong J Cell Death Dis; 2024 Oct; 15(10):733. PubMed ID: 39379360 [TBL] [Abstract][Full Text] [Related]
12. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex. Ma Q; Yang F; Huang B; Pan X; Li W; Yu T; Wang X; Ran L; Qian K; Li H; Li H; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Xiao B J Exp Clin Cancer Res; 2022 Aug; 41(1):251. PubMed ID: 35986300 [TBL] [Abstract][Full Text] [Related]
13. FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway. Azhati B; Reheman A; Dilixiati D; Rexiati M Arch Biochem Biophys; 2023 Jun; 741():109604. PubMed ID: 37080415 [TBL] [Abstract][Full Text] [Related]
14. FTO expression is associated with the occurrence of gastric cancer and prognosis. Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183 [TBL] [Abstract][Full Text] [Related]
15. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133 [TBL] [Abstract][Full Text] [Related]
16. FTO facilitates cancer metastasis by modifying the m Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739 [TBL] [Abstract][Full Text] [Related]
17. Fat mass and obesity-associated protein (FTO)-induced upregulation of flotillin-2 (FLOT2) contributes to cancer aggressiveness in diffuse large B-cell lymphoma (DLBCL) via activating the PI3K/Akt/mTOR signal pathway. Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A Arch Biochem Biophys; 2024 Aug; 758():110072. PubMed ID: 38914215 [TBL] [Abstract][Full Text] [Related]
18. m Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885 [TBL] [Abstract][Full Text] [Related]
19. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma. Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449 [TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m Zhou Y; Wang Q; Deng H; Xu B; Zhou Y; Liu J; Liu Y; Shi Y; Zheng X; Jiang J Cell Death Dis; 2022 Jan; 13(1):72. PubMed ID: 35064107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]